x

75% of people globally want unbiased news (Pew Research) but are concerned they're not getting that.

Get balanced coverage with Symby. See how stories are covered across diverse outlets and spot when one side covers a story the other skips.

PODCAST

touchPODCAST

Welcome to touchPODCAST where you can listen and learn from our expert faculty, hand-picked from the Touch Medical Media family of independent medical websites. Educating physicians on a fully global scale since 2005! We make positive changes to clinical practice, with the ultimate objective of improving patient and community health. Working alongside leading medical experts, societies and industry, our mission is to provide practical, expert opinions to support best practices for busy Healthcare

science

All Episodes

36:48

Understanding alopecia areata: Current perspectives...

touchPODCAST ·

2022/09/20

touchIN CONVERSATION for touchIMMUNOLOGY Listen to two expert dermatologists, Dr Maryanne Senna and Dr Anna Waśkiel-Burnat, discuss current understanding of alopecia areata, including the burden associated with the disease, its pathophysiology, and the potential role of emerging therapies in improving patient outcomes. The discussion is stimulated by questions posed by healthcare professionals involved in the management of alopecia areata. This touchPODCAST is for HCPs only. This activity is

en

47:42

Advancing the management of MDS and AML: Novel...

touchPODCAST ·

2022/09/12

touchEXPERT OPINIONS for touchONCOLOGY Listen to three experts describe the role of immune dysregulation in myelodysplastic syndromes (MDS) and acute myeloid leukaemia (AML), and summarize the rationale and available data for emerging immune-based therapeutic strategies. In a short panel discussion, they consider the possible impact these therapies may have on future clinical practice. The experts Prof. Dr. med. Uwe Platzbecker — University Hospital Leipzig, Leipzig, Germany Prof. Agnieszka

en

35:56

Experts in cytomegalovirus in solid organ transplants...

touchPODCAST ·

2022/09/05

touchEXPERT OPINIONS for touchRESPIRATORY Listen to three experts in cytomegalovirus (CMV) to learn about the unmet needs of solid organ transplant recipients susceptible to CMV infection. Topics covered will include management challenges in solid organ transplant recipients with CMV, the evolving antiviral options for refractory and resistant CMV, and best practice for the management of refractory/resistant CMV in these patients. The experts Dr Camille Kotton – Massachusetts General Hospital,

en

35:57

Experts in cytomegalovirus in solid organ transplants...

touchPODCAST ·

2022/09/02

touchEXPERT OPINIONS for touchINFECTIOUS DISEASES Listen to three experts in cytomegalovirus (CMV) to learn about the unmet needs of solid organ transplant recipients susceptible to CMV infection. Topics covered will include management challenges in solid organ transplant recipients with CMV, the evolving antiviral options for refractory and resistant CMV, and best practice for the management of refractory/resistant CMV in these patients. The experts Dr Camille Kotton – Massachusetts General

en

31:54

What’s new for eosinophilic esophagitis? A...

touchPODCAST ·

2022/08/18

touchEXPERT OPINIONS for touchRESPIRATORY Listen to three experts in eosinophilic oesophagitis (EoE) to learn about the aetiology, pathophysiology and clinical manifestations of EoE, as well as the practical aspects of its diagnosis and management in children and adults based on clinical case studies. The experts Dr Stuart Carr – Snö Asthma and Allergy, Abu Dhabi, UAE Dr Mário Vieira – Hospital Pequeno Príncipe, Curitiba, PR, Brazil Prof. Arjan Bredenoord – Amsterdam University Medical Center,

en

31:54

What’s new for eosinophilic esophagitis? A case-based...

touchPODCAST ·

2022/08/18

touchEXPERT OPINIONS for touchIMMUNOLOGY Listen to three experts in eosinophilic oesophagitis (EoE) to learn about the aetiology, pathophysiology and clinical manifestations of EoE, as well as the practical aspects of its diagnosis and management in children and adults based on clinical case studies. The experts Dr Stuart Carr – Snö Asthma and Allergy, Abu Dhabi, UAE Dr Mário Vieira – Hospital Pequeno Príncipe, Curitiba, PR, Brazil Prof. Arjan Bredenoord – Amsterdam University Medical Center,

en

56:51

Higher-risk MDS and newly diagnosed AML What are the...

touchPODCAST ·

2022/08/16

touchCONGRESS for touchONCOLOGY Listen to Dr Esther Oliva (Italy) review key data presented at the EHA 2022 Hybrid Congress on recent developments in the treatment of higher-risk MDS and newly diagnosed AML; she offers her expert insights on their potential impact on future clinical practice, alongside those from Prof. Michael Heuser (Germany) and Dr Yishai Ofran (Israel). OVERVIEW Data review with Dr Oliva (0:00) Expert interviews with Prof. Heuser, Dr Ofran and Dr Oliva, answering the questions

en

34:53

Advances in the first-line treatment of ES-SCLC: From...

touchPODCAST ·

2022/08/04

touchPANEL DISCUSSION for touchONCOLOGY Listen to a panel of leading lung cancer experts share their perspectives on recent advances in the first-line treatment of extensive-stage small cell lung cancer (ES-SCLC) and how they are changing clinical practice. The experts Dr Marina Garassino - University of Chicago, Chicago, IL, USA Dr Louis Paz-Ares - Hospital Universitario 12 de Octubre, Complutense University and Ciberonc, Madrid, Spain DR Martin Edelman - Fox Chase Cancer Center, Philadelphia, PA,

en

30:09

Investigating KRAS-G12C inhibitors: How might they...

touchPODCAST ·

2022/08/04

touchTALKS for touchONCOLOGY Listen to an esteemed lung cancer expert discuss KRAS mutations in solid tumours, particularly non-small cell lung cancer and colorectal cancer, and consider the role of direct KRAS-G12C inhibitors in targeting these mutations and potential strategies to overcome resistance. The expert: Prof. Tony Mok, Chinese University of Hong Kong, Hong Kong This touchPODCAST is for HCPs only. This activity is funded by an unrestricted independent medical education grant from

en

36:17

Improving outcomes for patients with advanced renal...

touchPODCAST ·

2022/08/04

touchIN CONVERSATION for touchONCOLOGY Listen to Dr Cristina Suárez, a clinician in Spain with a specialist focus on genitourinary tumors, in conversation with Dr Toni Choueiri, a renal cell carcinoma (RCC) expert. They respond to questions submitted by the HCP audience and provide their expert insights on how emerging combination therapies in the first-line setting can improve outcomes for patients with advanced RCC. This touchPODCAST is for HCPs only. This activity is funded by an unrestricted

en

35:45

Experts in paediatric endocrinology discuss the...

touchPODCAST ·

2022/08/03

touchIN CONVERSATION for touchENDOCRINOLOGY Listen to Dr Nadia Merchant in conversation with Dr Andrew Dauber. They respond to questions submitted by the HCP audience and provide their expert insights on the physiology of normal and abnormal bone growth, and the assessment and treatment of children with achondroplasia. This touchPODCAST is for HCPs only. This activity is funded by an unrestricted independent medical education grant from BioMarin. This activity is jointly provided by USF Health and

en

30:09

Investigating KRAS-G12C inhibitors: How might they...

touchPODCAST ·

2022/07/26

touchTALKS for touchRESPIRATORY Listen to an esteemed lung cancer expert discuss KRAS mutations in solid tumours, particularly non-small cell lung cancer and colorectal cancer, and consider the role of direct KRAS-G12C inhibitors in targeting these mutations and potential strategies to overcome resistance. The expert: Prof. Tony Mok, Chinese University of Hong Kong, Hong Kong This touchPODCAST is for HCPs only. This activity is funded by an unrestricted independent medical education grant from

en

01:04:33

Current and emerging treatments for chronic myeloid...

touchPODCAST ·

2022/07/20

touchCONGRESS for touchONCOLOGY Listen to Professor Giuseppe Saglio (Italy) cover key data presented at the EHA Hybrid Conference 2022 on the efficacy and safety of current and emerging treatments for CML, and how these may influence clinical practice, as well as expert insights and interpretation from Professor François-Xavier Mahon (France) and Professor Dietger Niederwieser (Germany). Overview Data review with Professor Giuseppe Saglio (00:54) Expert interview with Professor Giuseppe Saglio,

en

35:59

Maximizing the potential of PARP inhibitors as...

touchPODCAST ·

2022/07/19

touchIN CONVERSATION for touchONCOLOGY Listen to gynaecologic oncology specialists Prof. Nicoletta Colombo and Dr Natalia R Gómez-Hidalgo discuss three key topics relating to PARP inhibitors in the first-line maintenance setting for advanced ovarian cancer – rationale for use, which patients may particularly benefit, and key factors informing PARP inhibitor selection. Discussion on these themes is based on questions posed by healthcare professionals involved in the care of patients with ovarian

en

36:52

The practicalities of eosinophilic oesophagitis...

touchPODCAST ·

2022/07/08

touchPANEL DISCUSSION for touchIMMUNOLOGY Listen to key experts as they discuss the pathophysiology of eosinophilic oesophagitis (EoE) and provide their perspectives on the similarities and differences in its clinical presentation in children vs adults, the transition of care from paediatric to adult services, and the current and future treatment options for patients with EoE. The experts Dr Nirmala Gonsalves - Northwestern University Feinberg School of Medicine, Chicago, USA Dr Sharon Hall -

en

36:51

The practicalities of eosinophilic oesophagitis...

touchPODCAST ·

2022/07/08

touchPANEL DISCUSSION for touchRESPIRATORY Listen to key experts as they discuss the pathophysiology of eosinophilic oesophagitis (EoE) and provide their perspectives on the similarities and differences in its clinical presentation in children vs adults, the transition of care from paediatric to adult services, and the current and future treatment options for patients with EoE. The experts Dr Nirmala Gonsalves - Northwestern University Feinberg School of Medicine, Chicago, USA Dr Sharon Hall -

en

40:19

Treatment sequencing and the benefits of DMTs

touchPODCAST ·

2022/06/30

touchPANEL DISCUSSION for touchNEUROLOGY Listen to a panel of leading multiple sclerosis (MS) experts discuss their perspectives on the benefits of disease-modifying therapies (DMTs) in MS, and current approaches to treatment sequencing. The experts Prof. Gavin Giovannoni (Chair), Blizard Institute, Queen Mary University of London, UK Prof. Eva Havrdová, General Faculty Hospital, Charles University in Prague, Czech Republic Prof. Patrick Vermersch, Lille University Hospital, France This

en

41:10

Breast cancer specialists discuss risk stratification...

touchPODCAST ·

2022/06/15

touchPANEL DISCUSSION for touchONCOLOGY Listen to a panel of leading breast cancer specialists discuss their perspectives on risk stratification and future therapies in HR+ HER2- early breast cancer. The experts Dr Carlos Barrios - Hospital São Lucas PUCRS, Porto Alegre, Brazil Prof. Dr. med. Nadia Harbeck - University of Munich (LMU), Munich, Germany Prof. Chiun-Sheng Huang - National Taiwan University Hospital, Taipei City, Taiwan This touchPODCAST is for HCPs only. This activity is funded by an

en

34:38

How can real-world evidence guide the management of...

touchPODCAST ·

2022/06/13

touchIN CONVERSATION for touchONCOLOGY Listen to Dr Randy Broun, a community oncologist and haematologist, in conversation with Dr Faith Davies, a multiple myeloma expert. They respond to questions submitted by the HCP audience and provide their expert insights on how real-world evidence can guide the management of elderly and frail patients with multiple myeloma. This touchPODCAST is for HCPs only. This activity is funded by an unrestricted independent medical education grant from Takeda

en

38:09

Navigating the challenges of treatment provision in...

touchPODCAST ·

2022/05/26

touchPANEL DISCUSSION for touchONCOLOGY Listen to three experts discuss the treatment of recurrent/metastatic head and neck squamous cell carcinoma (HNSCC), including the latest clinical trial data and how it informs clinical practice, and how patient priorities can be established and incorporated into the care plan. The experts Prof. Lisa Licitra - Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy Dr Aline Chaves - DOM Oncology Group, Divinópolis, Brazil Prof. Joël Guigay - Cancer Center

en

532 results

Similar Podcasts

Classic Radio Science Fiction

solgoodmedia.com

Mission to Mars

Inception Point Ai

The 365 Days of Astronomy

365DaysOfAstronomy.org

Creek Devil

william Jevning

UFO Chronicles Podcast

Nik Hunter